Notice Pursuant to the National Cooperative Research and Production Act of 1993-Members of SGIP 2.0, Inc., 64508-64509 [2016-22590]
Download as PDF
64508
Federal Register / Vol. 81, No. 182 / Tuesday, September 20, 2016 / Notices
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Advanced Design
Consulting USA, Inc., Lansing, NY;
CheyTac USA, Nashville, GA; CoorsTek,
Inc., Golden, CO; CS Squared, LLC,
Fairfax, VA; Digital to Definitive, LLC,
Austin, TX; Florida Turbine
Technologies, Inc., Jupiter, FL; GPS
Source, Inc., Pueblo West, CO; II–VI
Optical Systems, Inc., Murrieta, CA;
Karagozian and Case, Inc., Glendale,
CA; MILSPRAY, LLC, Lakewood, NJ;
MTA, Inc., Huntsville, AL; Peregrine
Technical Solutions, LLC, Yorktown,
VA; QED Systems, LLC, Aberdeen
Proving Ground, MD; R2C Support
Services, Huntsville, AL; Radiance
Technologies, Inc., Huntsville, AL;
Scientia, LLC, Bloomington, IN;
Selective Intellect, LLC, Livingston, NJ;
and Technology Management Group,
Inc., King George, VA, have been added
as parties to this venture.
Also, OPTRA, Inc., Topsfield, MA;
Orion Munitions Development, LLC,
Gladstone, MO; and Trust Automation,
Inc., San Luis Obispo, CA, have
withdrawn as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and NAC intends
to file additional written notifications
disclosing all changes in membership.
On May 2, 2000, NAC filed its original
notification pursuant to section 6(a) of
the Act. The Department of Justice
published a notice in the Federal
Register pursuant to section 6(b) of the
Act on June 30, 2000 (65 FR 40693).
The last notification was filed with
the Department on May 31, 2016. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on July 6, 2016 (81 FR 44044).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2016–22591 Filed 9–19–16; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
sradovich on DSK3GMQ082PROD with NOTICES
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Medical Technology
Enterprise Consortium
Notice is hereby given that, on August
19, 2016, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Medical Technology
Enterprise Consortium (‘‘MTEC’’) has
VerDate Sep<11>2014
17:13 Sep 19, 2016
Jkt 238001
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, A.G.M. Biological Products
Development LTD, Nes Ziona, ISRAEL;
AbViro, LLC, Bethesda, MD; Actuated
Medical, Inc., Bellefonte, MD; applied
Medical Device Institute (aMDI) GVSU,
Grand Rapids, MI; Aptus, LLC,
Clemson, SC; ARMR Systems,
Snellville, GA; Axonova Medical, LLC,
Philadelphia, PA; Battelle Memorial
Institute, Columbus, OH; BioBridge
Global, San Antonio, TX; Brown
University, Providence, RI; Combat
Wounded Veteran Challenge, Inc., Saint
Petersburg, FL; DigitalDerm, Inc.,
Columbia, SC; GeoVax, Inc., Smyrna,
GA; Health Research, Inc./Wadsworth
Center, Menands, NY; IDIQ Inc.,
Fallbrook, CA; INCELL Corporation,
LLC, San Antonio, TX; Indiana
University, Indianapolis, IN; KIYATEC,
Inc., Greenville, SC; Longeveron, LLC,
Miami, FL; Lynntech, Inc., College
Station, TX; MetArmor, Inc., Glen
Garden, NJ; NGT–VC 2021 Limited
Partnership (NGT3), Nazareth, ISRAEL;
Northwestern University, Evanston, IL;
Organovo, Inc., San Diego, CA;
Propagenix, Inc., Rockville, MD;
Rhythmlink International, LLC,
Columbia, SC; Scientific & Biomedical
Microsystems, LLC (SBM), Glen Burnie,
MD; Strategic Marketing Innovations,
Inc., Washington, DC; Tonix
Pharmaceuticals, Inc., New York, NY;
University of California-Irvine, Irvine,
CA; University of Cincinnati,
Department of Surgery, Cincinnati, OH;
University of Maryland-Baltimore,
Baltimore, MD; and Virtech Bio, LLC,
New York, NY, have been added as
parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and MTEC
intends to file additional written
notifications disclosing all changes in
membership.
On May 9, 2014, MTEC filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on June 9, 2014 (79 FR 32999).
The last notification was filed with
the Department on March 15, 2016. A
notice was published in the Federal
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Register pursuant to Section 6(b) of the
Act on April 14, 2016 (81 FR 22119).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2016–22586 Filed 9–19–16; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Members of SGIP 2.0, Inc.
Notice is hereby given that, on August
10, 2016, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Members of SGIP
2.0, Inc. (‘‘MSGIP 2.0’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Red Hat, Inc., Raleigh, NC;
and Think Energy, Houston, TX, have
been added as parties to this venture.
Also, American Public Power
Association (APPA), Washington, DC;
ARC Informatique, Serves, FRANCE;
Cornice Engineering, Inc., Grand
Canyon, AZ; Elster Solutions, Raleigh,
NC; GridIntellect LLC, Madison, AL;
LocalGrid Technologies, Mississauga,
CANADA; Milbank Manufacturing Co.,
Kansas City, MO; National Instruments,
Austin, TX; Nikos Hatziargyriou
Technical Office Consultants, Athens,
GREECE; and Utilities Telecom Council,
Inc., Washington, DC, have withdrawn
as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and MSGIP 2.0
intends to file additional written
notifications disclosing all changes in
membership.
On February 5, 2013, MSGIP 2.0 filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on March 7, 2013 (78 FR
14836).
The last notification was filed with
the Department on April 12, 2016. A
notice was published in the Federal
E:\FR\FM\20SEN1.SGM
20SEN1
64509
Federal Register / Vol. 81, No. 182 / Tuesday, September 20, 2016 / Notices
Register pursuant to Section 6(b) of the
Act on May 18, 2016 (81 FR 31259).
Controlled substance
Noroxymorphone (9668) ..............
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
Schedule
II
[Docket No. DEA–392]
The company plans to manufacture
the above-listed controlled substances
as Active Pharmaceutical Ingredient
(API) for clinical trials.
In reference to drug codes 7360
(marihuana), and 7370 (THC), the
company plans to bulk manufacture
these drugs as synthetics. No other
activities for these drug codes are
authorized for this registration.
Bulk Manufacturer of Controlled
Substances Application: Patheon API
Manufacturing, Inc.
Dated: September 12, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–22590 Filed 9–19–16; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[FR Doc. 2016–22526 Filed 9–19–16; 8:45 am]
ACTION:
Notice of application.
BILLING CODE 4410–09–P
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before November 21, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on January
13, 2016, Patheon API Manufacturing,
Inc., 309 Delaware Street, Building
1106, Greenville, South Carolina 29605
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
sradovich on DSK3GMQ082PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Controlled substance
Schedule
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
VerDate Sep<11>2014
17:13 Sep 19, 2016
I
I
Jkt 238001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on April
4, 2015, R & D Systems, Inc., 614
McKinley Place NE., Minneapolis,
Minnesota 55413 applied to be
registered as an importer of the
following basic classes of controlled
substances:
Importer of Controlled Substances
Application: R & D Systems, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before October 20, 2016. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
October 20, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/ODW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearing on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
DATES:
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
Controlled substance
Mephedrone
(4-Methyl-Nmethylcathinone) (1248).
JWH–018 (also known as AM678)
(1-Pentyl-3-(1-naphthoyl)
indole) (7118).
CP–47,497
(5-(1,1Dimethylheptyl)-2-[(1R,3S)-3hydroxycyclohexyl-phenol)
(7297).
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
4-Bromo-2,5dimethoxyamphetamine (7391).
3,4Methylenedioxymethamphetamine (7405).
Dimethyltryptamine (7435) ...........
Psilocyn (7438) .............................
Pentobarbital (2270) .....................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Schedule
I
I
I
I
I
I
I
I
I
II
II
II
The company plans to manufacture
bulk active pharmaceutical controlled
substances for distribution to its
customers for analytical purposes.
In reference to drug codes 7360 and
7370, the company plans to import a
synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other activity
for these drug codes is authorized for
this registration.
Dated: September 12, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–22525 Filed 9–19–16; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\20SEN1.SGM
20SEN1
Agencies
[Federal Register Volume 81, Number 182 (Tuesday, September 20, 2016)]
[Notices]
[Pages 64508-64509]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22590]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Members of SGIP 2.0, Inc.
Notice is hereby given that, on August 10, 2016, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Members of SGIP 2.0, Inc.
(``MSGIP 2.0'') has filed written notifications simultaneously with the
Attorney General and the Federal Trade Commission disclosing changes in
its membership. The notifications were filed for the purpose of
extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, Red Hat, Inc., Raleigh, NC; and Think Energy, Houston,
TX, have been added as parties to this venture.
Also, American Public Power Association (APPA), Washington, DC; ARC
Informatique, Serves, FRANCE; Cornice Engineering, Inc., Grand Canyon,
AZ; Elster Solutions, Raleigh, NC; GridIntellect LLC, Madison, AL;
LocalGrid Technologies, Mississauga, CANADA; Milbank Manufacturing Co.,
Kansas City, MO; National Instruments, Austin, TX; Nikos Hatziargyriou
Technical Office Consultants, Athens, GREECE; and Utilities Telecom
Council, Inc., Washington, DC, have withdrawn as parties to this
venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MSGIP 2.0 intends to file additional
written notifications disclosing all changes in membership.
On February 5, 2013, MSGIP 2.0 filed its original notification
pursuant to Section 6(a) of the Act. The Department of Justice
published a notice in the Federal Register pursuant to Section 6(b) of
the Act on March 7, 2013 (78 FR 14836).
The last notification was filed with the Department on April 12,
2016. A notice was published in the Federal
[[Page 64509]]
Register pursuant to Section 6(b) of the Act on May 18, 2016 (81 FR
31259).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2016-22590 Filed 9-19-16; 8:45 am]
BILLING CODE P